|
Market Closed -
Other stock markets
|
After hours 18:00:11 | |||
| 214.17 USD | +1.22% |
|
215.02 | +0.40% |
| 12-15 | The Hain Celestial Group, Inc. Appoints Alison E. Lewis as President, Effective December 15, 2025 | CI |
| 12-15 | FDA awards national priority voucher to teclistamab | RE |
| Capitalization | 510B 434B 406B 381B 702B 46,261B 768B 4,730B 1,829B 21,756B 1,913B 1,872B 79,120B | P/E ratio 2025 * |
20.5x | P/E ratio 2026 * | 21.8x |
|---|---|---|---|---|---|
| Enterprise value | 526B 448B 419B 393B 724B 47,731B 792B 4,880B 1,887B 22,448B 1,973B 1,932B 81,635B | EV / Sales 2025 * |
5.61x | EV / Sales 2026 * | 5.28x |
| Free-Float |
77.08% | Yield 2025 * |
2.41% | Yield 2026 * | 2.49% |
Last Transcript: Johnson & Johnson
| 1 day | +0.40% | ||
| 1 week | +6.06% | ||
| Current month | +3.50% | ||
| 1 month | +9.31% | ||
| 3 months | +20.28% | ||
| 6 months | +36.33% | ||
| Current year | +48.09% |
| 1 week | 199.9 |  | 215.18 |
| 1 month | 195.9 | | 215.18 |
| Current year | 140.68 | | 215.18 |
| 1 year | 140.68 | | 215.18 |
| 3 years | 140.68 | | 215.18 |
| 5 years | 140.68 | | 215.18 |
| 10 years | 94.28 | | 215.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 62 | 2022-01-02 |
Joseph Wolk
DFI | Director of Finance/CFO | 58 | 2018-06-30 |
Penny M. Heaton
CTO | Chief Tech/Sci/R&D Officer | 60 | 2024-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anne Mulcahy
BRD | Director/Board Member | 72 | 2009-10-22 |
Mark McClellan
BRD | Director/Board Member | 61 | 2013-10-14 |
Mary Beckerle
BRD | Director/Board Member | 70 | 2015-06-08 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 14.01% | 303 M€ | -20.62% | - |
| 12.91% | 26 M€ | +11.49% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.22% | +6.06% | +46.07% | +19.14% | 510B | |
| +3.38% | +5.14% | +34.60% | +192.21% | 920B | |
| +1.85% | +0.61% | +31.19% | +37.97% | 395B | |
| +1.61% | +3.54% | +27.13% | +4.67% | 340B | |
| +1.25% | +0.15% | +30.03% | +19.40% | 278B | |
| +1.65% | +0.15% | +22.22% | +24.51% | 254B | |
| +0.81% | +0.54% | -1.71% | -10.12% | 249B | |
| -1.48% | +2.20% | -58.04% | -32.50% | 224B | |
| +2.38% | +1.27% | +22.07% | +22.23% | 171B | |
| +0.14% | -1.16% | +30.12% | +38.35% | 149B | |
| Average | +0.69% | +0.66% | +18.37% | +31.59% | 349.14B | |
| Weighted average by Cap. | +0.64% | +1.20% | +24.55% | +61.45% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 93.76B 79.78B 74.65B 70.11B 129B 8,508B 141B 870B 336B 4,002B 352B 344B 14,552B | 98.48B 83.8B 78.41B 73.64B 136B 8,937B 148B 914B 353B 4,203B 369B 362B 15,285B |
| Net income | 24.7B 21.02B 19.67B 18.47B 34.01B 2,241B 37.21B 229B 88.63B 1,054B 92.67B 90.71B 3,834B | 23.45B 19.95B 18.67B 17.53B 32.28B 2,128B 35.32B 218B 84.14B 1,001B 87.97B 86.1B 3,639B |
| Net Debt | 16.2B 13.79B 12.9B 12.11B 22.31B 1,470B 24.41B 150B 58.14B 691B 60.78B 59.5B 2,515B | 10.33B 8.79B 8.23B 7.73B 14.23B 938B 15.57B 95.87B 37.08B 441B 38.77B 37.95B 1,604B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-15 | 214.17 $ | +1.22% | 8,424,432 |
| 25-12-12 | 211.58 $ | +0.75% | 6,922,683 |
| 25-12-11 | 210.01 $ | +1.68% | 9,008,960 |
| 25-12-10 | 206.54 $ | +3.29% | 11,599,785 |
| 25-12-09 | 199.96 $ | -0.82% | 7,509,402 |
Delayed Quote Nyse, December 15, 2025 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- JNJ Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition